139 related articles for article (PubMed ID: 15899749)
1. Cost-effectiveness of a behavioral intervention for seropositive youth.
Lee MB; Leibowitz A; Rotheram-Borus MJ
AIDS Educ Prev; 2005 Apr; 17(2):105-18. PubMed ID: 15899749
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
[TBL] [Abstract][Full Text] [Related]
3. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
Dowdy DW; Sweat MD; Holtgrave DR
AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia.
Guinot D; Ho MT; Poynten IM; McAllister J; Pierce A; Pell C; Grulich AE
HIV Med; 2009 Apr; 10(4):199-208. PubMed ID: 19207598
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of adult circumcision in a resource-rich setting for HIV prevention among men who have sex with men.
Anderson J; Wilson D; Templeton DJ; Grulich A; Carter R; Kaldor J
J Infect Dis; 2009 Dec; 200(12):1803-12. PubMed ID: 19909084
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness.
Johnson-Masotti AP; Pinkerton SD; Kelly JA; Stevenson LY
AIDS Care; 2000 Jun; 12(3):321-32. PubMed ID: 10928210
[TBL] [Abstract][Full Text] [Related]
8. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
Holtgrave DR
PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
[TBL] [Abstract][Full Text] [Related]
9. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda.
Gray RH; Li X; Kigozi G; Serwadda D; Nalugoda F; Watya S; Reynolds SJ; Wawer M
AIDS; 2007 Apr; 21(7):845-50. PubMed ID: 17415039
[TBL] [Abstract][Full Text] [Related]
10. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
12. AVERT: a user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission.
Rehle TM; Saidel TJ; Hassig SE; Bouey PD; Gaillard EM; Sokal DC
AIDS; 1998; 12 Suppl 2():S27-35. PubMed ID: 9792359
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
[TBL] [Abstract][Full Text] [Related]
14. An HIV-preventive intervention for youth living with HIV.
Lightfoot M; Rotheram-Borus MJ; Tevendale H
Behav Modif; 2007 May; 31(3):345-63. PubMed ID: 17438347
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of community-based physical activity interventions.
Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
[TBL] [Abstract][Full Text] [Related]
16. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
Ekwueme DU; Weniger BG; Chen RT
Bull World Health Organ; 2002; 80(11):859-70. PubMed ID: 12481207
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
[TBL] [Abstract][Full Text] [Related]
18. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
19. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
20. Discussing HIV serostatus with prospective sex partners: a potential HIV prevention strategy among high-risk men who have sex with men.
Rietmeijer CA; Lloyd LV; McLean C
Sex Transm Dis; 2007 Apr; 34(4):215-9. PubMed ID: 17179774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
